Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Syndax banks an $80M crossover round for PhIII cancer drug
Syndax banks an $80M crossover round for PhIII cancer drug
Syndax banks an $80M crossover round for PhIII cancer drug
Submitted by
admin
on August 24, 2015 - 11:32am
Source:
Fierce Biotech
News Tags:
Syndax Pharma
IPOs
breast cancer
Headline:
Syndax banks an $80M crossover round for PhIII cancer drug
Do Not Allow Advertisers to Use My Personal information
